Chiltern

PharmaTimes clinical research awards to be presented Feb. 26

Thursday, February 12, 2015 03:33 PM

The 2015’s PharmaTimes Clinical Researcher of the Year—The Americas awards will be presented Feb. 26 in North Carolina.

More... »


Chiltern earns five spots in PharmaTimes Clinical Researcher of the Year finals

Thursday, January 29, 2015 10:47 AM

Chiltern, a global CRO, has earned five nominations in the PharmaTimes Clinical Researcher of the Year finals for the project manager, clinical research associate (CRA) and new CRA categories.

More... »


Chiltern launches rebranding

Monday, November 3, 2014 02:37 PM

U.K.-based Chiltern has rebranded as a completely integrated and unified CRO with services that are "Designed Around You.”

More... »

Chiltern acquires Pacific Clinical Research, expands in Asia-Pacific

Monday, September 29, 2014 01:24 PM

Chiltern, a global clinical CRO, has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The move allows Chiltern to offer integrated services throughout the Asia-Pacific region and strengthens its oncology and anti-infective offerings.

More... »

Chiltern acquires Ockham, strengthening oncology, CRO services, job placement

Tuesday, July 15, 2014 03:38 PM

U.K.-based Chiltern, a 32-year-old global CRO specializing in oncology services and a range of other therapeutic areas, has acquired Ockham, a 28-year-old oncology-focused CRO, and the two companies will merge their operations.

More... »

Chiltern wins CRO leadership award from Life Science Leader

Friday, March 7, 2014 09:31 AM

Global CRO Chiltern has been recognized with a CRO Leadership Award in all five categories: Quality, Reliability, Productivity, Innovation and Regulatory. The awards are given by Life Science Leaderpublication based on the data-driven research of Nice Insight. Chiltern is the only organization to be recognized in all five categories for three straight years.

More... »

Chiltern partners with Karolinska Development

Thursday, February 13, 2014 01:59 PM

Global CRO Chiltern International has partnered with Karolinska Development, a Sweden-based life science investment company. Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. An exclusive deal flow agreement with Karolinska Institutet Innovations, along with other cooperation agreements with universities, delivers a continuous flow of innovations.

More... »

Chiltern wins Pharmatimes awards

Thursday, February 6, 2014 11:10 AM

Global CROChiltern International has won two awards at the PharmaTimes Annual Awards 2014 ceremony that took place in London on Jan. 30. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

More... »

Kester Capital sells Chiltern

Thursday, January 2, 2014 10:54 AM

Kester Capital, the European private equity arm of Greenhill & Co., has sold its interest in Chiltern in a deal valuing the company at $223.4 million. The exit comes as Chiltern announces the consolidation of existing investors, led by Sir Douglas Myers. The transaction has generated a return of over two times capital and a 25% IRR for Kester Capital funds.

More... »

PharmaTimes recognizes top U.S. clinical researchers

Tuesday, November 19, 2013 01:00 PM

Winners of the U.S. Clinical Researcher of the Year competition were announced following an intense finals day hosted by partner SAS at its global headquarters in Cary, N.C.

More... »


CWWeekly

February 23

Venture capital investors funding novel drug R&D three times more than companies repurposing, improving existing drugs

In appreciation: Karen Woodin will be remembered for her teaching, writing and lasting friendships

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs